dihydrotestosterone has been researched along with Alopecia Circumscripta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irwig, MS | 1 |
| Beamer, WG; King, LE; McElwee, KJ; Silva, K; Sundberg, JP | 1 |
| Weigand, DA | 1 |
| Ebling, FJ | 1 |
2 review(s) available for dihydrotestosterone and Alopecia Circumscripta
| Article | Year |
|---|---|
Recent developments in alopecias.
Topics: Alopecia; Alopecia Areata; Androgens; Dihydrotestosterone; Female; Humans; Male; Protein-Energy Malnutrition; Scalp | 1978 |
Hair.
Topics: Alopecia; Alopecia Areata; Depression, Chemical; Dihydrotestosterone; Estrogens; Female; Hair; Hair Removal; Humans; Male; Mitosis; Skin Transplantation; Testosterone; Thyroxine; Transplantation, Autologous | 1976 |
2 other study(ies) available for dihydrotestosterone and Alopecia Circumscripta
| Article | Year |
|---|---|
Androgen levels and semen parameters among former users of finasteride with persistent sexual adverse effects.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia Areata; Dihydrotestosterone; Finasteride; Humans; Male; Sexual Dysfunction, Physiological; Sperm Count; Sperm Motility; Spermatozoa; Testosterone | 2014 |
Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata.
Topics: Alopecia Areata; Animals; Dihydrotestosterone; Estradiol; Female; Gonads; Male; Melanocytes; Mice; Mice, Inbred C3H; Orchiectomy; Ovariectomy; Severity of Illness Index | 2001 |